• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.

作者信息

Chongsrisawat Voranush, Suratannon Narissara, Chatchatee Pantipa, Ittiwut Rungnapa, Ittiwut Chupong, Weerapakorn Wanlapa, Theamboonlers Apiradee, Rohlfs Meino, Klein Christoph, Kotlarz Daniel, Suphapeetiporn Kanya

机构信息

Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.

Pediatric Allergy and Clinical Immunology Research Unit, Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand.

出版信息

Inflamm Bowel Dis. 2022 Sep 1;28(9):1458-1461. doi: 10.1093/ibd/izac001.

DOI:10.1093/ibd/izac001
PMID:35134932
Abstract
摘要

相似文献

1
Novel CD55 Mutation Associated With Severe Small Bowel Ulceration Mimicking Inflammatory Bowel Disease in a Pair of Siblings.一对患有类似炎症性肠病的严重小肠溃疡的兄弟姐妹中与新型CD55突变相关的病例
Inflamm Bowel Dis. 2022 Sep 1;28(9):1458-1461. doi: 10.1093/ibd/izac001.
2
CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis.CD55缺乏、早发性蛋白丢失性肠病与血栓形成
N Engl J Med. 2017 Jul 6;377(1):52-61. doi: 10.1056/NEJMoa1615887. Epub 2017 Jun 28.
3
CHAPLE syndrome uncovers the primary role of complement in a familial form of Waldmann's disease.CHAPLE 综合征揭示了补体在家族性 Waldmann 病中的主要作用。
Immunol Rev. 2019 Jan;287(1):20-32. doi: 10.1111/imr.12715.
4
CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) variant.布哈拉犹太人的 CD55 缺乏症是由克朗默血型 Dr(a-)变体引起的。
Hum Genet. 2023 May;142(5):683-690. doi: 10.1007/s00439-021-02428-3. Epub 2022 Mar 21.
5
Interleukin-10 receptor mutation presenting with severe nappy ulceration and infantile inflammatory bowel disease.伴有严重尿布疹溃疡和婴儿炎症性肠病的白细胞介素-10受体突变
Clin Exp Dermatol. 2017 Oct;42(7):771-773. doi: 10.1111/ced.13157. Epub 2017 Jun 9.
6
Decay-accelerating factor deficiency increases susceptibility to dextran sulfate sodium-induced colitis: role for complement in inflammatory bowel disease.衰变加速因子缺乏增加了对葡聚糖硫酸钠诱导的结肠炎的易感性：补体在炎症性肠病中的作用
J Immunol. 2004 Mar 15;172(6):3836-41. doi: 10.4049/jimmunol.172.6.3836.
7
Eculizumab-Responsive Adult Onset Protein Losing Enteropathy, Caused by Germline CD55-Deficiency and Complicated by Aggressive Angiosarcoma.由种系CD55缺乏引起并伴有侵袭性血管肉瘤的依库珠单抗反应性成人起病的蛋白丢失性肠病。
J Clin Immunol. 2021 Feb;41(2):477-481. doi: 10.1007/s10875-020-00910-7. Epub 2020 Nov 19.
8
Eculizumab Is Safe and Effective as a Long-term Treatment for Protein-losing Enteropathy Due to CD55 Deficiency.依库珠单抗作为 CD55 缺乏导致的蛋白丢失性肠病的长期治疗方法是安全有效的。
J Pediatr Gastroenterol Nutr. 2019 Mar;68(3):325-333. doi: 10.1097/MPG.0000000000002198.
9
The small intestine in cardiac cachexia: a forgotten player of the game.心脏恶病质中的小肠：这场游戏中被遗忘的参与者。
Int J Cardiol. 2011 Feb 17;147(1):186-7. doi: 10.1016/j.ijcard.2010.12.039. Epub 2010 Dec 28.
10
Inflammatory Bowel Disease and Small Bowel Cancer Risk, Clinical Characteristics, and Histopathology: A Population-Based Study.炎症性肠病与小肠癌风险、临床特征和组织病理学：一项基于人群的研究。
Clin Gastroenterol Hepatol. 2017 Dec;15(12):1900-1907.e2. doi: 10.1016/j.cgh.2017.06.051. Epub 2017 Jul 8.

引用本文的文献

1
Population pharmacokinetic analyses of pozelimab in patients with CD55-deficient protein-losing enteropathy (CHAPLE disease).在 CD55 缺陷性蛋白丢失性肠病（CHAPLE 病）患者中进行 pozelimab 的群体药代动力学分析。
J Pharmacokinet Pharmacodyn. 2024 Dec;51(6):905-917. doi: 10.1007/s10928-024-09941-8. Epub 2024 Sep 30.
2
Breaking Down Barriers: Epithelial Contributors to Monogenic IBD Pathogenesis.突破障碍：单基因炎症性肠病发病机制中的上皮细胞贡献者。
Inflamm Bowel Dis. 2024 Jul 3;30(7):1189-1206. doi: 10.1093/ibd/izad319.
3
Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study.
评价 pozelimab 在补体过度激活、血管病变性血栓形成和蛋白丢失性肠病伴有 CD55 缺陷患者中的疗效和安全性：一项开放标签的 2 期和 3 期研究。
Lancet. 2024 Feb 17;403(10427):645-656. doi: 10.1016/S0140-6736(23)02358-9. Epub 2024 Jan 23.